StockMacro
Menu

Claritev

$18.28 -16% in 6 monthsMarket cap $312.1M

CTEV on XNYS, Services, Claritev Corporation, job postings

Measures activity, not value. Not investment advice.

Shares fell 60% in a year and the company lost $275.1M, but insiders bought $5.4M of stock.

  • BadDebt of $4.6B against cash of $10.1M on the balance sheet
  • GoodQuarterly revenue rose 9.1% to $268.3M from a year earlier

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Industry
Services-business services, nec (Services)
Employees
3,000
Website
claritev.com
Listed
NYSE, US
Last results
7 Aug 2026
Next results
expected around 22 Feb 2027 (an estimate: a year ago it reported on 23 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $268.3M, net loss $61.8M.
Quarter to 31 Dec 2021: revenue $298.3M, net income $24.9MQuarter to 31 Dec 2021: revenue $298.3M, net income $24.9MQuarter to 31 Mar 2022: revenue $298.0M, net income $44.0MQuarter to 31 Mar 2022: revenue $298.0M, net income $44.0MQuarter to 30 Jun 2022: revenue $290.1M, net income $13.5MQuarter to 30 Jun 2022: revenue $290.1M, net income $13.5MQuarter to 30 Sep 2022: revenue $250.5M, net income $19.7MQuarter to 30 Sep 2022: revenue $250.5M, net income $19.7MQuarter to 31 Dec 2022: revenue $241.1M, net income -$650.1MQuarter to 31 Dec 2022: revenue $241.1M, net income -$650.1MQuarter to 31 Mar 2023: revenue $236.6M, net income $209KQuarter to 31 Mar 2023: revenue $236.6M, net income $209KQuarter to 30 Jun 2023: revenue $238.0M, net income -$36.4MQuarter to 30 Jun 2023: revenue $238.0M, net income -$36.4MQuarter to 30 Sep 2023: revenue $242.8M, net income -$24.1MQuarter to 30 Sep 2023: revenue $242.8M, net income -$24.1MQuarter to 31 Dec 2023: revenue $244.1M, net income -$31.4MQuarter to 31 Dec 2023: revenue $244.1M, net income -$31.4MQuarter to 31 Mar 2024: revenue $234.5M, net income -$539.7MQuarter to 31 Mar 2024: revenue $234.5M, net income -$539.7MQuarter to 30 Jun 2024: revenue $233.5M, net income -$576.7MQuarter to 30 Jun 2024: revenue $233.5M, net income -$576.7MQuarter to 30 Sep 2024: revenue $230.5M, net income -$391.4MQuarter to 30 Sep 2024: revenue $230.5M, net income -$391.4MQuarter to 31 Dec 2024: revenue $232.1M, net income -$138.0MQuarter to 31 Dec 2024: revenue $232.1M, net income -$138.0MQuarter to 31 Mar 2025: revenue $231.3M, net income -$71.3MQuarter to 31 Mar 2025: revenue $231.3M, net income -$71.3MQuarter to 30 Jun 2025: revenue $241.6M, net income -$62.6MQuarter to 30 Jun 2025: revenue $241.6M, net income -$62.6MQuarter to 30 Sep 2025: revenue $246.0M, net income -$69.8MQuarter to 30 Sep 2025: revenue $246.0M, net income -$69.8MQuarter to 31 Dec 2025: revenue $246.6M, net income -$80.6MQuarter to 31 Dec 2025: revenue $246.6M, net income -$80.6MQuarter to 31 Mar 2026: revenue $244.7M, net income -$73.6MQuarter to 31 Mar 2026: revenue $244.7M, net income -$73.6MQuarter to 30 Jun 2026: revenue $257.5M, net income -$59.2MQuarter to 30 Jun 2026: revenue $257.5M, net income -$59.2MQuarter to 30 Sep 2026: revenue $268.3M, net income -$61.8MQuarter to 30 Sep 2026: revenue $268.3M, net income -$61.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $650.1M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$268.3M-$61.8M
30 Jun 2026$257.5M-$59.2M
31 Mar 2026$244.7M-$73.6M
31 Dec 2025$246.6M-$80.6M
30 Sep 2025$246.0M-$69.8M
30 Jun 2025$241.6M-$62.6M
31 Mar 2025$231.3M-$71.3M
31 Dec 2024$232.1M-$138.0M
30 Sep 2024$230.5M-$391.4M
30 Jun 2024$233.5M-$576.7M
31 Mar 2024$234.5M-$539.7M
31 Dec 2023$244.1M-$31.4M
30 Sep 2023$242.8M-$24.1M
30 Jun 2023$238.0M-$36.4M
31 Mar 2023$236.6M$209K
31 Dec 2022$241.1M-$650.1M
30 Sep 2022$250.5M$19.7M
30 Jun 2022$290.1M$13.5M
31 Mar 2022$298.0M$44.0M
31 Dec 2021$298.3M$24.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.0B $951.0M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +6.9% +9.7%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$275.1M -$341.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$16.42 -$20.91
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 40.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 4.2% -0.5% 7.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -27.1% -35.9% 5.9%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. – 10.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$27.8M -$112.5M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $10.1M $39.2M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $4.6B $4.6B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $4.6B $4.6B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.57
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. –
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 25.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.31 1.5
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 4.9 1.8
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. – 2.4

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
ClaritevCTEV (this company) $312.1Mloss0.31+6.9%-27.1%
Advantage SolutionsADV $314.5Mloss0.09+2.9%-8.9%
Iron Horse Acquisitions IIIRHO $296.9M66.0–––
OutdoorPOWW $290.4M39.35.2+13%13.3%
RepayRPAY $343.7Mloss0.83+34%-41.2%
AlightALIT $247.0Mloss0.11-4.0%-46.0%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$3.2M

bought $5.4M, sold $2.2M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+4.0%

105 13F filers vs 101

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

89%

15.2M shares held by 13F filers (30 Sep 2026) of 17.1M outstanding (2 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.5%

770K shares sold short (30 Oct 2026) of 17.1M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.9

770K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-16%

917K shares sold short in the report before, 770K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

42%

42% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 63%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

+147%

42 vs 17 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+9.1%

$268.3M vs $246.0M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+23%

$44.4M vs $36.2M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$960K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

7

7 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

7.0×

7 articles in the last 7 days; its usual week has 1.

Price $18.28 on 20 Nov 2026, -60% over 12 months (12-month range $13.47 to $54.87)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $3.9M in the last 12 months (the 12 months before: -$70.3M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 42 published in the last 12 months, +147% on the 12 months before.
Revenue per quarter. Revenue $268.3M in the latest quarter, +9.1% on a year earlier.
Capital spending per quarter. Capital spending $44.4M in the latest quarter, +23% on a year earlier.
Institutional holders (13F filers). 105 13F filers reported holding it in the latest 13F quarter, +17% on a year earlier.
Lobbying spend. Lobbying spend: $960K published in the last 12 months, -3.0% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
15 Oct 20268-K and other filingsDirector or officer change
15 Sep 20268-K and other filingsDirector or officer change
15 Sep 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 May 2026Lobbying filinglobbying engagement terminated (FORBES-TATE)
30 Apr 20268-K and other filingsDirector or officer change
30 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Mar 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 639K)
29 Dec 20258-K and other filingsDirector or officer change
29 Dec 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Nov 2025Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 426K)
26 Sep 20258-K and other filingsDirector or officer change
26 Sep 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Jun 2025Lobbying filingnew lobbying registration (ALSTON & BIRD LLP)
17 May 2025Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 742K)
1 May 20258-K and other filingsDirector or officer change
5 Mar 20258-K and other filingsDirector or officer change
30 Jan 20258-K and other filingsA major agreement ended
31 Dec 20248-K and other filingsDirector or officer change
31 Dec 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
23 Sep 2024Lobbying filingnew lobbying registration (CLARITEV (FORMERLY MULTIPLAN CORPORATION))
10 Sep 20248-K and other filingsDirector or officer change
9 Aug 2024Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 635K)
1 Aug 20248-K and other filingsDirector or officer change
27 Jun 2024Lobbying filingnew lobbying registration (FORBES-TATE)
27 Jun 2024Sharp changeFirst lobbying registration: first lobbying registration: CLARITEV (FKA MULTIPLAN CORPORATION): new lobbying registration (FORBES-TATE)
10 May 20248-K and other filingsDirector or officer change
26 Apr 20248-K and other filingsDirector or officer change
29 Mar 20248-K and other filingsDelisting notice or listing transfer
7 Mar 20248-K and other filingsDirector or officer change
4 Jan 20248-K and other filingsDirector or officer change
4 Jan 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Jan 20248-K and other filingsDelisting notice or listing transfer
28 Jun 20238-K and other filingsDirector or officer change
28 Jun 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 May 20238-K and other filingsCompleted an acquisition or asset sale
3 Mar 20238-K and other filingsDirector or officer change
8 Dec 20228-K and other filingsDirector or officer change
8 Dec 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Aug 20228-K and other filingsDirector or officer change
4 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
31 Jan 20228-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Dec 2021: $1.3M published
Month from 1 Aug 2022: -$17.3M published
Month from 1 Nov 2022: $51K published
Month from 1 May 2024: $96K published
Month from 1 Aug 2024: $635K published
Month from 1 Nov 2024: $250K published
Month from 1 Mar 2025: $277K published
Month from 1 May 2025: $1.2M published
Month from 1 Aug 2025: $549K published
Month from 1 Nov 2025: -$72.3M published
Month from 1 Mar 2026: $909K published
Month from 1 May 2026: $469K published
Month from 1 Jun 2026: $25K published
Month from 1 Aug 2026: -$643K published
Month from 1 Sep 2026: -$26K published
Month from 1 Oct 2026: $1.5M published
Month from 1 Nov 2026: $1.7M published
H-1B/E-3 applications certified
Quarter from 1 Oct 2025: 17 published
Quarter from 1 Jan 2026: 9 published
Quarter from 1 Apr 2026: 11 published
Quarter from 1 Jul 2026: 11 published
Quarter from 1 Oct 2026: 11 published
Revenue per quarter
Quarter ended 31 Dec 2021: $298.3M, +17% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $298.0M, +17% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $290.1M, +5.0% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $250.5M, -13% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $241.1M, -19% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $236.6M, -21% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $238.0M, -18% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $242.8M, -3.1% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $244.1M, +1.3% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $234.5M, -0.9% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $233.5M, -1.9% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $230.5M, -5.1% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $232.1M, -4.9% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $231.3M, -1.4% on a year earlier; public on 10 May 2025
Quarter ended 30 Jun 2025: $241.6M, +3.5% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $246.0M, +6.7% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $246.6M, +6.2% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $244.7M, +5.8% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $257.5M, +6.6% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $268.3M, +9.1% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $27.4M, +27% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $24.5M, +35% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $18.9M, +1.5% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $20.8M, +2.0% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Dec 2022: $25.5M, -6.8% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $23.1M, -5.5% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $32.0M, +69% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $22.4M, +7.7% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $31.3M, +23% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $30.5M, +32% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $25.4M, -20% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $31.7M, +41% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $30.4M, -2.9% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $38.9M, +27% on a year earlier; public on 10 May 2025
Quarter ended 30 Jun 2025: $24.6M, -3.2% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $36.2M, +14% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $29.9M, -1.7% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $46.8M, +20% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $38.1M, +55% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $44.4M, +23% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 133; public on 14 Feb 2022
31 Mar 2022 report: 132; public on 16 May 2022
30 Jun 2022 report: 135; public on 15 Aug 2022
30 Sep 2022 report: 130; public on 14 Nov 2022
31 Dec 2022 report: 133; public on 14 Feb 2023
31 Mar 2023 report: 126; public on 15 May 2023
30 Jun 2023 report: 118; public on 14 Aug 2023
30 Sep 2023 report: 114; public on 14 Nov 2023
31 Dec 2023 report: 112; public on 14 Feb 2024
31 Mar 2024 report: 108; public on 15 May 2024
30 Jun 2024 report: 104; public on 14 Aug 2024
30 Sep 2024 report: 57; public on 14 Nov 2024
31 Dec 2024 report: 50; public on 14 Feb 2025
31 Mar 2025 report: 54; public on 15 May 2025
30 Jun 2025 report: 70; public on 14 Aug 2025
30 Sep 2025 report: 90; public on 14 Nov 2025
31 Dec 2025 report: 100; public on 17 Feb 2026
31 Mar 2026 report: 90; public on 15 May 2026
30 Jun 2026 report: 101; public on 14 Aug 2026
30 Sep 2026 report: 105; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jul 2024: $40K published
Quarter from 1 Oct 2024: $190K published
Quarter from 1 Jan 2025: $210K published
Quarter from 1 Apr 2025: $220K published
Quarter from 1 Jul 2025: $280K published
Quarter from 1 Oct 2025: $280K published
Quarter from 1 Jan 2026: $270K published
Quarter from 1 Apr 2026: $530K published
Quarter from 1 Oct 2026: $160K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is lobbying spend reported (quarter) at $160K (30 Sep 2026), 36% below its normal reading of $250K; higher than 20% of its own history.
  • Insider net buying (open market): Insiders bought a net $3.9M in the last 12 months (the 12 months before: -$70.3M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 42 published in the last 12 months, +147% on the 12 months before.
  • Revenue per quarter: Revenue $268.3M in the latest quarter, +9.1% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 55 insider trades

Last 90 days: 3 sales, $2.2M; 5 purchases, $5.4M. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
16 Nov 2026Ares Management LLC and 7 others10% ownerBuy13,587$28.73$390KForm 4
13 Nov 2026Travis DaltonPres., CEO & Executive ChairBuy5,110$29.34$150KForm 4
12 Nov 2026Michael Stuart KleinDirectorSell65,567$27.72$1.8MForm 4
12 Nov 2026Ares Management LLC and 7 others10% ownerBuy115,579$25.40$2.9MForm 4
27 Oct 2026Ares Management LLC and 7 others10% ownerBuy70,834$23.69$1.7MForm 4
16 Oct 2026Tiffani MisencikSVP, Chief Growth OfficerSellplanned in advance (10b5-1)5,812$23.81$138KForm 4
22 Sep 2026Douglas Michael GarisEVP&CFOSellplanned in advance (10b5-1)9,025$30.59$276KForm 4
31 Aug 2026Travis DaltonPres., CEO & Executive ChairBuy6,450$38.71$250KForm 4

105 institutions reported shares at the end of Q3 2026, 89% of the shares outstanding; 16 opened a position, 11 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
H&F Corporate Investors VIII, Ltd.3.9M22.8%$82.3MNo change
Ares Management LLC1.9M10.9%$39.4MNo change
Arini Capital Management Ltd1.5M8.99%$32.5M-1.5M-50%
Public Investment Fund1.3M7.50%$27.1MNo change
BlackRock, Inc.773K4.53%$16.4M+50K+6.9%
Beach Point Capital Management LP751K4.40%$15.9M-20K-2.6%
Vanguard Capital Management LLC586K3.43%$12.4M+163K+39%
CPV Partners, LLC495K2.90%$10.5MNo change
Prudential Financial Inc377K2.21%$8.0M+24K+6.6%
JPMorgan Chase & Co354K2.07%$7.7M+350K83 times as many

Company events

All 48 company events

In 12 months: 4 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
15 Oct 2026Director or officer change8-K
15 Sep 2026Director or officer change8-K
30 Apr 2026Director or officer changeSame filing: shareholder vote results8-K
29 Dec 2025Director or officer change8-K
26 Sep 2025Director or officer change8-K
1 May 2025Director or officer changeSame filing: shareholder vote results8-K
5 Mar 2025Director or officer change8-K
30 Jan 2025Signed a major agreement; A major agreement endedSame filing: took on new debt8-K

Reported lobbying spend: $160K in Q3 2026, $230K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
14 May 2026EndedForbes-Tatefor Claritev (Fka Multiplan Corporation)Issues pertaining to payment for healthcare services and healthcare data transparency.; Issues related to anti-trust.; Issues related to payment for healthcare services; Issues related to healthcare data transparency.Medicare/Medicaid, Labor, Health issuesFiling
20 May 2025NewAlston & Bird LLPfor ClaritevIssues related to healthcare reimbursement; issues related to payment and revenue integrity.Health issues, Medicare/MedicaidFiling
12 Aug 2024NewClaritev (Formerly Multiplan Corporation)its own lobbyistsIssues pertaining to payment for healthcare services.Health issuesFiling
1 Jun 2024NewForbes-Tatefor Claritev (Fka Multiplan Corporation)Issues pertaining to payment for healthcare services.Health issuesFiling

The 5 newest of 75 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 17 Nov 2026Insiders record

    ARES MANAGEMENT LLC (ten percent owner) and 3 other(s) bought 13,587 shares of CTEV [same transaction as an earlier filing] (dated 16 Nov 2026)

  2. 17 Nov 2026Insiders record

    ARES MANAGEMENT LLC (ten percent owner) and 7 other(s) bought 13,587 shares of CTEV ($390,403) (dated 16 Nov 2026)

  3. 13 Nov 2026Insiders record

    Dalton Travis (Pres., CEO & Executive Chair) bought 5,110 shares of CTEV ($149,927)

  4. 12 Nov 2026Insiders record

    ARES MANAGEMENT LLC (ten percent owner) and 3 other(s) bought 115,579 shares of CTEV [same transaction as an earlier filing]

  5. 12 Nov 2026Insiders record

    ARES MANAGEMENT LLC (ten percent owner) and 7 other(s) bought 115,579 shares of CTEV ($2.9M)

  6. 27 Oct 2026Insiders record

    ARES MANAGEMENT LLC (ten percent owner) and 3 other(s) bought 70,834 shares of CTEV [same transaction as an earlier filing]

  7. 27 Oct 2026Insiders record

    ARES MANAGEMENT LLC (ten percent owner) and 7 other(s) bought 70,834 shares of CTEV ($1.7M)

  8. 15 Oct 2026Filings record

    Director or officer change

  9. 15 Sep 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 15 Sep 2026Filings record

    Director or officer change

  11. 1 Sep 2026Insiders record

    Dalton Travis (Pres., CEO & Executive Chair) bought 6,450 shares of CTEV ($249,681) (dated 31 Aug 2026)

  12. 11 Jun 2026Insiders record

    Carol Nutter (SVP, Chief People Officer) bought 875 shares of CTEV ($24,859) (dated 10 Jun 2026)

  13. 22 May 2026Lobbying record

    CLARITEV (FKA MULTIPLAN CORPORATION): lobbying engagement terminated (FORBES-TATE) (dated 14 May 2026)

  14. 20 May 2026Insiders record

    Dalton Travis (Pres., CEO & Executive Chair) bought 20,920 shares of CTEV ($258,638) (dated 19 May 2026)

  15. 20 May 2026Insiders record

    Kim Michael (EVP, Chief Digital Officer) bought 3,000 shares of CTEV ($49,950) (dated 19 May 2026)

  16. 20 May 2026Insiders record

    Prince John Michael (director) bought 10,000 shares of CTEV ($160,000) (dated 19 May 2026)

  17. 30 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 30 Apr 2026Filings record

    Director or officer change

  19. 17 Mar 2026Insiders record

    Kim Michael (EVP, Chief Digital Officer) bought 15,000 shares of CTEV ($247,500) (dated 16 Mar 2026)

  20. 17 Mar 2026Insiders record

    Garis Douglas Michael (EVP&CFO) bought 1,300 shares of CTEV ($22,997) (dated 16 Mar 2026)

  21. 3 Mar 2026Insiders change

    had 3 insiders buy $639K of its shares on the open market within 30 days (3 filings).

    Who bought: O'Neil Tara, Kim Michael, Dalton Travis.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $639K
    Window
    1 Feb 2026 to 3 Mar 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  22. 3 Mar 2026Insiders record

    Dalton Travis (Pres., CEO & Executive Chair) bought 15,380 shares of CTEV ($199,940) (dated 2 Mar 2026)

  23. 3 Mar 2026Insiders record

    Kim Michael (EVP, Chief Digital Officer) bought 30,000 shares of CTEV ($429,000) (dated 2 Mar 2026)

  24. 3 Mar 2026Insiders record

    O'Neil Tara (SVP, General Counsel) bought 750 shares of CTEV ($9,742) (dated 2 Mar 2026)

  25. 29 Dec 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 29 Dec 2025Filings record

    Director or officer change

  27. 21 Nov 2025Insiders record

    Dalton Travis (Pres., CEO & Executive Chair) bought 5,290 shares of CTEV ($249,847) (dated 20 Nov 2025)

  28. 20 Nov 2025Insiders change

    had 3 insiders buy $426K of its shares on the open market within 30 days (3 filings).

    Who bought: O'Neil Tara, Kim Michael, Mintz William B..

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $426K
    Window
    21 Oct 2025 to 20 Nov 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  29. 20 Nov 2025Insiders record

    Mintz William B. (SVP, Chief Strategy Officer) bought 916 shares of CTEV ($34,808) (dated 19 Nov 2025)

  30. 19 Nov 2025Insiders record

    Kim Michael (EVP, Chief Digital Officer) bought 9,600 shares of CTEV ($367,200) (dated 18 Nov 2025)

  31. 19 Nov 2025Insiders record

    O'Neil Tara (SVP, General Counsel) bought 625 shares of CTEV ($24,275) (dated 18 Nov 2025)

  32. 26 Sep 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 26 Sep 2025Filings record

    Director or officer change

  34. 13 Aug 2025Insiders record

    Dalton Travis (Pres., CEO & Executive Chair) bought 4,282 shares of CTEV ($248,414) (dated 12 Aug 2025)

  35. 12 Aug 2025Insiders record

    Hogge Jerome (EVP, Chief Operating Officer) bought 5,621 shares of CTEV ($300,780) (dated 11 Aug 2025)

  36. 24 Jun 2025Lobbying record

    CLARITEV: new lobbying registration (ALSTON & BIRD LLP) (dated 20 May 2025)

  37. 21 May 2025Insiders record

    Garis Douglas Michael (EVP&CFO) bought 3,600 shares of CTEV ($99,828) (dated 20 May 2025)

  38. 21 May 2025Insiders record

    Hogge Jerome (EVP, Chief Operating Officer) bought 12,500 shares of CTEV ($349,250) (dated 20 May 2025)

  39. 17 May 2025Insiders change

    had 3 insiders buy $742K of its shares on the open market within 30 days (3 filings).

    Who bought: O'Neil Tara, Garis Douglas Michael, Dalton Travis.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $742K
    Window
    17 Apr 2025 to 17 May 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  40. 17 May 2025Insiders record

    Dalton Travis (Pres., CEO & Executive Chair) bought 3,773 shares of CTEV ($99,984) (dated 16 May 2025)

Showing the newest 40 of 111 entries; narrow the window or the kind of data to see older ones.

Not listed: 91 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001793229
Ticker
CTEV
Domain
claritev.com
Employer name
Claritev Corporation, MultiPlan, Inc., Multiplan, Inc. (d/b/a Claritev), MultiPlan Inc. DBA Claritev Inc. (4 unverified)
Fein
13-3068979 (1 unverified)
Hq location
VA|MCLEAN|22102 (1 unverified)
Lobbying client
claritev, claritev fka multiplan, claritev formerly multiplan
Name
Admar Corporation, American Lifecare Holdings, Inc, American Lifecare, Inc, Beech Street Corporation and 37 more
Wikidata
Q132544684
  • DOL H-1B labor condition applications and PERM certifications209 data points20 Jan 2025 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)4 records, 30 data points1 Jun 2024 to 30 Sep 2026
  • SEC Form 13F institutional holdings2 records, 225 data points30 Sep 2020 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)122 records29 Jan 2020 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)387 data points31 Dec 2017 to 2 Nov 2026
  • SEC Form 4 insider transactions55 records, 164 data points8 Oct 2020 to 16 Nov 2026
  • FINRA short interest (twice monthly)123 data points28 Feb 2025 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)872 data points28 Feb 2025 to 20 Nov 2026